Addictive Disorders in Medical Populations

Norman S. Miller, Mark S. Gold (Herausgeber)

Buch | Hardcover

646 Seiten

2010
John Wiley & Sons Inc (Verlag)
978-0-470-74033-0 (ISBN)

Titel z.Zt. nicht lieferbar
Versandkostenfrei
Auch auf Rechnung

Artikel merken

Drug and alcohol addictions occur commonly in medical populations; 25-50% of patients seen by primary care physicians have alcohol and drug disorders, with even higher prevalence in certain medical specialty populations.

This book has a much wider focus than traditional books written about drug and alcohol addictions. This unique book is written by medical specialists who diagnose, treat and research addictive disorders in their specialities. Thus, it meets the needs of the typical medical practitioner who wants to learn about and treat patients with addictive disorders in their practices. Because alcohol and drug problems are so prevalent and affect medical conditions profoundly, the medical specialist will improve their knowledge and skill to diagnose and treat addictive disorders in their specialties. Drug and alcohol addictions occur commonly in medical populations; 25–50% of patients seen by primary care physicians have alcohol and drug disorders, with even higher prevalence in certain medical specialty populations. Drug use (including illicit drug use and actual or perceived misuse of prescribed medications), alcohol use, and what has been called unhealthy drinking are even more common in trauma centers and our society. Currently, there are no authoritative addiction texts that focus on the identification, intervention and management of either “addictive disorders in medical populations” or “medical complications in addiction populations”.

Neurobiological progress in the field of addiction has been amazing and evidence-based treatments have developed at a phenomenal pace, with bench to office applications for tobacco, alcohol and drugs. Pharmacological and psychosocial treatments are described here in detail and in practical terms. The medical and mental complications of addiction are explained comprehensively throughout the text. Clinical considerations are the predominant theme, with the standards of clinical practice grounded in the most current research. The chapters include practical presentations of both clinical and research materials, with instruments for screening and assessment and treatment.

It will be useful for all those seeking information to help a patient or family with a tobacco, alcohol or drug problem. We hope this book can give answers and direction to the identification and management of addictions and their medical complications in patient populations.

Dr. Miller has spent 25 years in clinical practice and teaching and research at Cornell University Medical College, the University of Illinois at Chicago; he currently serves as a Clinical Professor at the College of Human Medicine at Michigan State University and works as a psychiatrist at Pine Rest Christian Mental Health Services in Grand Rapids. He has published 250 medical/scientific articles, book chapters, and reviews, and 12 books on addiction medicine. He is a fellow in the American Psychopathological Association, and a member of the American Psychiatric Association, the American Society for Addiction Medicine, and the American National Professional Committees. He is a member of the Task Force on Treatment for the Office of National Drug Control Policy, Office of the President of the United States; a member of the Center for Substance Abuse Treatment on Screening, Assessment, and Treatment Planning for patients with Coexisting Mental Illness and Alcohol and Other Drug Abuse; and co-chair of the Task Force for Undergraduate Medical Education, Association for Medical Education and Research ing Substance Abuse. For the American Society for Addiction Medicine, he is Regional Director of the Midwest Region and Editor of Principles of Addiction Medicine (First Edition), Program and Publication Committees. He has coordinated symposia, courses and workshops for the ASAM annual meeting. Mark S. Gold, M.D. is an editor, author, teacher, pioneer, researcher and inventor, who has worked for nearly 40 years to create models for understanding the effects of tobacco, opiates and other drugs on the brain and behavior. He has developed models that have led to the discovery of new addiction treatments and has conceptualized novel hypotheses which yielded new approaches to the definition and treatment of addictions. Dr. Gold's pioneering work on the brain systems underlying the effects of opiate drugs led to a dramatic change in the way opiate action was understood and his seminal work on cocaine is considered classic translational science. Over the past decade, he has defined hedonic overeating as an addiction and developed animal and imaging models to develop new treatments for overeating and obesity. Most recently, he and his colleagues demonstrated that intravenously administered anesthetics and analgesics are exhaled in the air of operating rooms, present on surfaces, and available for second hand exposure. Dr. Gold and colleagues have explained the role of the workplace environment in physician drug abuse, addictions and relapse after successful treatment. Under his leadership, the Department of Psychiatry at the University of Florida has grown to 60 full-time clinical physicians and researchers with new projects and research groups in secondhand exposure models, functional brain imaging, self-administration, public health, impaired professionals, genomics, proteomics and nanotechnology. Dr. Gold has been awarded numerous national prizes and recognition for his work, leadership, and mentoring. Since beginning his career in research at the University of Florida in 1970, he has been the author of over 900 medical articles, chapters, and abstracts in journals for health professionals on a wide variety of psychiatric research subjects and has authored 12 professional books including practice guidelines, ASAM core competencies, and medical text books for primary care professionals. He is the author of 15 general audience books. According to a review in the Journal of the American Medical Association (JAMA 272:18, 1996), "Mark S. Gold, M.D. the most prolific and brilliant of the addiction experts writing today... Dr. Gold has spent his career trying to bridge the gap in medical education and practice with the belief that addictions are diseases and that all physicians have a critical role in prevention and, if that fails, in early identification and prompt treatment."

List of Contributors ix

Preface xiii

Acknowledgements xv

Part One Addictive Disorders and Medicine 1

1 Addictive Disorders as an Integral Part of the Practice of Medicine 3
Norman S. Miller and Mark S. Gold

2 Crime, Substance Use, and Mental Illness 15
Joel M. Silberberg, Milap A. Nowrangi, and Geetha Nampiaparampil

3 Ethical Issues in Addiction Medicine 31
Roberta Springer Loewy

4 Natural History of Addictive Diseases 53
Steven A. Branstetter and Sabina Low

5 Prevention Methods: School, Family, Community, Media and Public Policy Approaches 73
Karol L. Kumpfer and Paula Smith

Part Two Assessment and Diagnosis 97

6 Screening and Diagnosis of Substance Use Disorders 99
Norman G. Hoffman

7 Clinical Pharmacology of Addicting Drugs 107
Jiang Liu and Hartmut Derendorf

8 Laboratory Diagnosis of Addicting Drugs 125
K.P. Gunaga and Satheesh Gunaga

9 Cutaneous Manifestations of Drug Addiction 143
Kendra Gail Bergstrom and Miguel R. Sanchez

Part Three Addictive Disorders and Clinical Diseases 155

10 Addictive Disorders in Primary Care Medicine 157
Robert Mallin

11 Addictive Disorders in the Intensive Care Unit 167
Tracy R. Luckhardt and Robert C. Hyzy

12 Addictive Disorders in Trauma Center Patients 181
Mary C. McCarthy and Kathryn M. Tchorz

13 Addictive Disorders in Psychiatric Medicine 197
Christine Yuodelis-Flores, W. Murray Bennett, Charles Meredith, and Richard Ries

14 Addiction and Short-Term Pain Management 219
Steven D. Passik, Lauren J. Rogak, Tatiana D. Starr, and Kenneth L. Kirsh

15 Prescription Opiate Medications: Clinical Assessment and Treatment of Tolerance and Dependence 227
Norman S. Miller, Lucy Chen, and Jianren Mao

16 Substance Addiction and HIV Infection: Scope of the Problem and Management 239
Gabriel Sarah, Clifford Martin, Myles Stone, Carol Schneiderman, and Stephen A. Klotz

17 Addictive Disorders in Cardiovascular Medicine 251
Alan H. Gradman and Nosheen Javed

18 Alcohol Use and Diseases of the Eye 277
Yoshimune Hiratsuka

19 Addictive Disorders in Nutritional Diseases - From an Addictions Viewpoint 287
James A. Cocores, Noni A. Graham, and Mark S. Gold

20 Addictive Disorders in Nutritional Diseases - From a Nutritional Viewpoint 303
Jennifer A. Nasser, Jessica B. Leitzsch, and Kiran Patel

21 Gastrointestinal Diseases Associated with Substance Addiction 313
Paul S. Haber and Abdullah Demirkol

22 Addictive Disorders in Malignant Diseases 339
Thomas J. Guzzo and Mark L. Gonzalgo

23 Substance Addiction and Gastrointestinal Malignancy 347
Jason T. Hedrick and James R. Ouellette

24 Renal Manifestations of Recreational Drug Use 361
Garland A. Campbell, W. Kline Bolton, and Mitchell H. Rosner

25 Addictive Disorder in Urological Diseases 377
Herman S. Bagga and Adam W. Levinson

Part Four Management of Addictive Disorders in Selected Populations 387

26 Management of Addictive Disorders in Medical Nursing Care Populations 389
Kathleen L. Becker and Benita J. Walton-Moss

27 Management of Addictive Disorders in Surgical Nursing Care Practice 411
Phyllis J. Mason

28 Addictive Disorders in Psychology Practice 421
Lisa J. Merlo

29 Addictive Disorders in Diseases of Women 439
Deborah V. Gross, C. Chapman Sledge, and Ellen A. Ovson

30 Children and Adolescents with ADHD: Risk and Protective Factors for Addictive Disorders 455
Larry Gray, Jennifer J. Park, and Michael E. Msall

31 Addictive Disorders in the Elderly 467
Andrea Bial

Part Five Treatment of Addictive Disorders 481

32 Pharmacological Therapeutics for Detoxification in Addictive Disorders 483
Firas H. Kobeissy, Carolina F. Braga, Noni A. Graham, and Mark S. Gold

33 Pharmacological Therapeutics for Relapse Reduction in Addictive Disorders 503
Lisa J. Merlo, Kimberly G. Blumenthal, Kendall Campbell, Morrow Omli, and Mark S. Gold

34 Psychosocial Treatments for Addictive Disorders: Models, Settings, and Important Roles for Referring Physicians 525
John McKellar, John Finney, and Rudolf Moos

35 Treatment Models for Comorbid Psychiatric and Addictive Disorders 541
Jon D. Kassel, Adrienne J. Heinz, Daniel P. Evatt, and Ashley R. Braun

36 Brief Interventions for Alcohol and Drug Problems 557
Kristen L. Barry, Laurie Brockmann, and Frederic C. Blow

37 Treatment Outcomes for Addictive Disorders 575
Erin L. Winstanley, Shannon K. Bolon, and Marc Fishman

38 Biopsychosocial Recovery from Addictive Disorders 603
Sara Jo Nixon and Robert A. Prather

Index 619

Erscheint lt. Verlag	14.9.2010
Verlagsort	New York
Sprache	englisch
Maße	196 x 254 mm
Gewicht	1393 g
Einbandart	gebunden
Themenwelt	Geisteswissenschaften ► Psychologie
Themenwelt	Medizin / Pharmazie ► Medizinische Fachgebiete ► Suchtkrankheiten
ISBN-10	0-470-74033-7 / 0470740337
ISBN-13	978-0-470-74033-0 / 9780470740330
Zustand	Neuware